Clinical trial related to rehabilitation of patients with Alzheimer:
cross sectional study
DOI:
https://doi.org/10.34024/rnc.2020.v28.10165Keywords:
Alzheimer’s Disease, PEDro Database, Clinical Trial, Methodological QualityAbstract
Introduction. Alzheimer's is a degenerative and progressive neurological disease, with a prevalence about 60 to 70% of diagnosed dementia cases. Objective. To describe the main characteristics of physiotherapy clinical trials related to the rehabilitation of Alzheimer disease’s (AD) patients, published in the PEDro database; to rank, by the impact factor, the main journals that publish studies in this area; and to analyze the correlation between methodological quality, impact factor and time of publication. Method. The PEDro database search selected all clinical trials, aimed at rehabilitation of AD patients, extracting the following data language, year and time of publication, methodological quality, sample size, intervention, comparison, and impactor factor from all journals. Spearman's correlation coefficient was calculated to explore the relationships between the variables. Results. We found 93 studies published in 58 journals. The mean number of participants per study was 102±155 subjects, most of them published in the English language (97%). The mean PEDro score of the studies was 5.5±1.5. General exercises were the main type of treatment used (43%), compared to another type of intervention (41%). The mean impact factor of the journals was 6.7±11.6. No significant correlation was found between any of the variables. Conclusion. The trials related to the rehabilitation of AD patients shoed, in general, moderate methodological quality. Studies are mostly published in journals with high impact factor (mean of 6.7). Finally, both current and older studies, may have good methodological quality, regardless of the impact factor of the journal.
Metrics
References
Smith MAC. Doença de Alzheimer. Rev Bras Psiquiatr 1999;21:1-5. http://dx.doi.org/10.1590/S1516-44461999000600003
Huang CY, Chen YA, Hwang IS, Wu RM. Improving dual- task control with a posture-second strategy in early-stage parkinson disease. Arch Phys Med Rehabil 2018;99:1540-6.
http://dx.doi.org/10.1016/j.apmr.2018.02.013
Whitfield JA, Goberman AM. Speech motor sequence learning: Effect of Parkinson disease and normal aging on dual-task performance. J Speech Lang Hear Res 2017;60:1752-65.
http://dx.doi.org/10.1044/2017_JSLHR-S-16-0246
Santos-Picanco LC, Ozela PF, Brito MF, Pinheiro AA, Padilha EC, Braga FS, et al. Alzheimer’s Disease: A review from the pathophysiology to diagnosis, new perspectives for pharmacological treatment. Curr Med Chem 2018;25:3141-59.
http://dx.doi.org/10.2174/0929867323666161213101126
Vergara-Diaz G, Osypiuk K, Hausdorff JM, Bonato P, Gow BJ, Miranda JG, et al. Tai chi for reducing dual-task gait variability, a potential mediator of fall risk in parkinson’s disease: a pilot randomized controlled trial. Glob Adv Health Med 2018;7:2164956118775385. http://dx.doi.org/10.1177/2164956118775 385
Aprahamian I, Martinelli JE, Yassuda MS. Doença de Alzheimer: revisão da epidemiologia e diagnóstico. Rev Bras Clín Med 2009;7:27-35. http://files.bvs.br/upload/S/1679-1010/2009/v7n1/a27-35.pdf
Guimarães CHS, Malena LMA, Limborço-Filho M, Martins FR. Demência e a doença de Alzheimer no processo de envelhecimento: fisiopatologia e abordagem terapêutica. Rev Saúde Foco 2018;10:942-55. http://portal.unisepe.com.br/unifia/wp-content/uploads/sites/10001/2018/12/108_DEM%C3%8ANCIA-E-A-DOEN%C3%87A-DE-ALZHEIMER.pdf
Marques CLS, Borgato MH, Neto EM, Bazan R, Luvizutto GJ. Physical therapy in patients with Alzheimer’s disease: a systematic review of randomized controlled clinical trials. Fisioter Mov 2019;26:311-21. http://dx.doi.org/10.1590/1809-2950/18037226032019
Christofoletti G, Oliani MM, Bucken-Gobbi LT, Gobbi S, Beinotti F, Stella F. Physical activity attenuates neuropsychiatric disturbances and caregiver burden in patients with dementia. Clinics 2011;66:613-8. http://dx.doi.org/10.1590/S1807-59322011000400015
Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000;342:1878-86. http://dx.doi.org/10.1056/NEJM200006223422506
Moseley AM, Elkins MR, Janer-Duncan L, Hush JM. The quality of reports of randomized controlled trials varies between subdisciplines of physiotherapy. Physiother Can 2014;66:36-43.
http://dx.doi.org/10.3138/ptc.2012-68
Hariohm K, Jeyanthi S, Kumar JS, Prakash V. Description of interventions is under-reported in physical therapy clinical trials. Braz J Phys Ther 2017;21:281–6.
http://dx.doi.org/10.1016/j.bjpt.2017.05.006
Ahn C, Ahn D. Randomized clinical trials in stroke research. J Investig Med 2010;58:277–81.
http://dx.doi.org/10.2310/JIM.0b013e31 81c9b2d4
Nascimento DP, Gonzalez GZ, Araujo AC, Costa LOP. Description of low back pain clinical trials in physical therapy: a cross sectional study. Braz J Phys Ther 2019;23:448-57.
http://dx.doi.org/10.1016/j.bjpt.2018.09.002
Michaleff ZA, Costa LO, Moseley AM, Maher CG, Elkins MR, Herbert RD, et al. CENTRAL, PEDro, PubMed, and EMBASE are the most comprehensive databases indexing randomized controlled trials of physical therapy interventions. Phys Ther 2011;91:190-7. http://dx.doi.org/10.2522/ptj.20100116
Moseley AM, Sherrington C, Elkins MR, Herbert RD, Maher CG. Indexing of randomised controlled trials of physiotherapy interventions: a comparison of AMED, CENTRAL, CINAHL, EMBASE, hooked on evidence, PEDro, PsycINFO and PubMed. Physiotherapy 2009;95:151-6. http://dx.doi.org/10.1016/j.physio.2009. 01.006
de Morton NA. The PEDro scale is a valid measure of the methodological quality of clinical trials: a demographic study. Australian Aust J Physiother 2009;55:129-33. http://dx.doi.org/10.1016/s0004-9514(09)70043-1
Maher CG, Sherrington C, Herbert RD, Moseley AM, Elkins M. Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther 2003;83:713-21.
https://doi.org/10.1093/ptj/83.8.713
Yamato TP, Maher C, Koes B, Moseley A. The PEDro scale had acceptably high convergent validity, construct validity, and interrater reliability in evaluating methodological quality of pharmaceutical trials. J Clin Epidemiol 2017;86:176-81.
http://dx.doi.org/10.1016/j.jclinepi.2017.03.002
Shiwa SR, Costa LOP, Moser ADL, Aguiar IC, Oliveira LVF. PEDro: a base de dados de evidências em fisioterapia. Fisioter Mov 2011;24:523-33. http://dx.doi.org/10.1590/S0103-51502011000300017
Cohen J. Statistical power analysis for the behavioral sciences. 2. ed. Nova York: Lawrence Erlbaum; 1988.
http://www.utstat.toronto.edu/~brunner/oldclass/378f16/readings/CohenPower.pdf
Zhang D, Freemantle N, Cheng KK. Are randomized trials conducted in China or India biased? A comparative empirical analysis. J Clin Epidemiol 2011;64:90-5.
http://dx.doi.org/10.1016/j.jclinepi.2010.02.010
Song F, Parekh S, Hooper L, Loke YK, Ryder J, Sutton AJ, et al. Dissemination and publication of research findings: an updated review of related biases. Health Technol Assess 2010;14:iii,ix-xi,1-193. http://dx.doi.org/10.3310/hta14080
Trinquart L, Dunn AG, Bourgeois FT. Registration of published randomized trials: a systematic review and meta-analysis. BMC Med 2018;16:173. http://dx.doi.org/10.1186/s12916-018-1168-6
Buchbinder R, van Tulder M, Öberg B, Costa LM, Woolf A, Schoene M, et al. Low back pain: a call for action. Lancet 2018;391:2384-8. http://dx.doi.org/10.1016/S0140-6736(18)30488-4
Hernández SS, Sandreschi PF, da Silva FC, Arancibia BA, da Silva R, Gutierres PJ, et al. What are the Benefits of Exercise for Alzheimer's Disease? A Systematic Review of the Past 10 Years. J Aging Phys Act 2015;23:659-68. http://dx.doi.org/10.1123/japa.2014-0180
Sloane PD, Zimmerman S, Suchindran C, Reed P, Wang L, Boustani M, et al. The public health impact of Alzheimer’s disease, 2000–2050: Potential implication of treatment advances. Annu Rev Public Health 2002;23:213-31. http://dx.doi.org/10.1146/annurev.publhealth.23.100901.140525
Downloads
Published
Issue
Section
How to Cite
Accepted 2020-03-12
Published 2020-05-08
